Reduced CTLA-4 expression on circulating CD19+ B cells and CD4+ or CD8+ T cells in patients with primary proliferative and nonproliferative glomerulonephritis versus control participants was suggested to contribute to continuous activation of T cells and pathogenesis (29). The gene discussed is CD8A; the disease is glomerulonephritis.